{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:59:24Z","timestamp":1787500764112,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s13730-016-0240-3","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T03:29:43Z","timestamp":1477884583000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A case of PR3\u2013ANCA-positive anti-GBM disease associated with intrarenal arteritis and thrombotic microangiopathy"],"prefix":"10.1007","volume":"6","author":[{"given":"Shun","family":"Manabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyasu","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"240_CR1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1523-1755.2003.00241.x","volume":"64","author":"CD Pusey","year":"2003","unstructured":"Pusey CD. Anti-glomerular basement membrane disease. Kidney Int. 2003;64:1535\u201350.","journal-title":"Kidney Int"},{"key":"240_CR2","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2353\/ajpath.2009.090533","volume":"175","author":"JA G\u00f3mez-Puerta","year":"2009","unstructured":"G\u00f3mez-Puerta JA, Bosch X. Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update. Am J Pathol. 2009;175:1790\u20138.","journal-title":"Am J Pathol"},{"key":"240_CR3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s10157-011-0435-z","volume":"15","author":"K Nakabayashi","year":"2011","unstructured":"Nakabayashi K, Fujioka Y, Arimura Y, et al. Anti-glomerular basement membrane (anti-GBM) disease accompanied by vasculitis that was not positive for antineutrophil cytoplasmic antibodies to myeloperoxidase and proteinase 3: a report of two cases and the incidence of anti-GBM disease at one institution. Clin Exp Nephrol. 2011;15:504\u201313.","journal-title":"Clin Exp Nephrol."},{"key":"240_CR4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0272-6386(95)90489-1","volume":"26","author":"AK Short","year":"1995","unstructured":"Short AK, Esnault VL, Lockwood CM, et al. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995;26:439\u201345.","journal-title":"Am J Kidney Dis"},{"key":"240_CR5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1681\/ASN.V83376","volume":"8","author":"T Hellmark","year":"1997","unstructured":"Hellmark T, Niles JL, Collins AB, et al. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol. 1997;8:376\u201385.","journal-title":"J Am Soc Nephrol"},{"key":"240_CR6","doi-asserted-by":"crossref","first-page":"c59","DOI":"10.1159\/000072022","volume":"94","author":"M Segelmark","year":"2003","unstructured":"Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture\u2019s disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies. Nephron Clin Pract. 2003;94:c59\u201368.","journal-title":"Nephron Clin Pract."},{"key":"240_CR7","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","volume":"66","author":"JB Levy","year":"2004","unstructured":"Levy JB, Hammad T, Coulthart A, et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66:1535\u201340.","journal-title":"Kidney Int"},{"key":"240_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ajkd.2005.05.003","volume":"46","author":"A Rutgers","year":"2005","unstructured":"Rutgers A, Slot M, van Paassen P, et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis. 2005;46:253\u201362.","journal-title":"Am J Kidney Dis"},{"key":"240_CR9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1681\/ASN.2006111210","volume":"18","author":"R Yang","year":"2007","unstructured":"Yang R, Hellmark T, Zhao J, et al. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2007;18:1338\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"240_CR10","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1093\/ndt\/gfn179","volume":"23","author":"W Kitagawa","year":"2008","unstructured":"Kitagawa W, Imai H, Komatsuda A, et al. The HLA-DRB1*1501 allele is prevalent among Japanese patients with anti-glomerular basement membrane antibody-mediated disease. Nephrol Dial Transplant. 2008;23:3126\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"240_CR11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1744-9987.2009.00724.x","volume":"13","author":"J Lindi\u010d","year":"2009","unstructured":"Lindi\u010d J, Vizjak A, Ferluga D, et al. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Ther Apheresis Dial. 2009;13:278\u201381.","journal-title":"Ther Apheresis Dial"},{"key":"240_CR12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/oxfordjournals.ndt.a027362","volume":"11","author":"P Neary","year":"1996","unstructured":"Neary P, Kadlubowski M, Thomson D, et al. Antiglomerular basement membrane disease with cANCA positivity without pulmonary involvement. Nephrol Dial Transplant. 1996;11:693\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"240_CR13","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.V8111795","volume":"8","author":"R Kalluri","year":"1997","unstructured":"Kalluri R, Meyers K, Mogyorosi A, et al. Goodpasture syndrome involving overlap with Wegener\u2019s granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol. 1997;8:1795\u2013800.","journal-title":"J Am Soc Nephrol"},{"key":"240_CR14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/ndt\/gfl751","volume":"22","author":"A Desai","year":"2007","unstructured":"Desai A, Goldschmidt RA, Kim GC. Sequential development of pulmonary renal syndrome associated with c-ANCA 3\u00a0years after development of anti-GBM glomerulonephritis. Nephrol Dial Transplant. 2007;22:926\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"240_CR15","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/ndt\/gfn092","volume":"23","author":"M Andrassy","year":"2008","unstructured":"Andrassy M, Sis J, Waldherr R, et al. The patient with C-ANCA\/PR3-ANCA-positive crescentic pauci-immune glomerulonephritis and recurrence of nephritic sediment. Nephrol Dial Transplant. 2008;23:2084\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"240_CR16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1053\/j.ajkd.2009.04.026","volume":"54","author":"S Clyne","year":"2009","unstructured":"Clyne S, Frederick C, Arndt F, et al. Concurrent and discrete clinicopathological presentations of Wegener granulomatosis and anti-glomerular basement membrane disease. Am J Kidney Dis. 2009;54:1116\u201320.","journal-title":"Am J Kidney Dis"},{"key":"240_CR17","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3899\/jrheum.091404","volume":"37","author":"S Mulpuru","year":"2010","unstructured":"Mulpuru S, Touchie C, Karpinski J, et al. Coexistent Wegener\u2019s granulomatosis and Goodpasture\u2019s disease. J Rheumatol. 2010;37:1786\u20137.","journal-title":"J Rheumatol"},{"key":"240_CR18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4103\/1319-2442.113886","volume":"24","author":"K Waqar","year":"2013","unstructured":"Waqar K, Sonia Y, Syed FM. Double positive Goodpasture\u2019s syndrome with Concomitant Active Pulmonary Tuberculosis. Saudi J Kidny Dis Transpl. 2013;24:783\u20138.","journal-title":"Saudi J Kidny Dis Transpl"},{"key":"240_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2169\/internalmedicine.31.239","volume":"31","author":"Y Arimura","year":"1992","unstructured":"Arimura Y, Minoshima S, Kamiya Y, et al. A case of Goodpasture\u2019s syndrome associated with anti-myeloperoxidase antibodies. Intern Med. 1992;31:239\u201343.","journal-title":"Intern Med"},{"key":"240_CR20","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1053\/j.ajkd.2003.11.019","volume":"43","author":"J Serratrice","year":"2004","unstructured":"Serratrice J, Chiche L, Dussol B, et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis. 2004;43:e26\u201330.","journal-title":"Am J Kidney Dis"},{"key":"240_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0272-6386(99)70366-5","volume":"34","author":"CA Verburgh","year":"1999","unstructured":"Verburgh CA, Bruijn JA, Daha MR, et al. Sequential development of anti-GBM nephritis and ANCA-associated Pauci-immune glomerulonephritis. Am J Kidney Dis. 1999;34:344\u20138.","journal-title":"Am J Kidney Dis"},{"key":"240_CR22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2009.07.015","volume":"55","author":"K O\u2019Connor","year":"2010","unstructured":"O\u2019Connor K, Fulcher D, Phoon RK. Development of anti-glomerular basement membrane disease after remission from perinuclear ANCA-associated glomerulonephritis in a patient with HLA susceptibility. Am J Kidney Dis. 2010;55:566\u20139.","journal-title":"Am J Kidney Dis"},{"key":"240_CR23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/ajkd.2003.50142","volume":"41","author":"A Vizjak","year":"2003","unstructured":"Vizjak A, Rott T, Koselj-Kajtna M, et al. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis. 2003;41:539\u201349.","journal-title":"Am J Kidney Dis"},{"key":"240_CR24","first-page":"S53","volume":"26","author":"A Knight","year":"2008","unstructured":"Knight A, Ekbom A, Brandt L, et al. What is the significance in routine care of c-ANCA\/PR3-ANCA in the absence of systemic vasculitis? A case series. Clin Exp Rheumatol. 2008;26:S53\u20136.","journal-title":"Clin Exp Rheumatol."},{"key":"240_CR25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/RHU.0b013e31826d2005","volume":"18","author":"SP McAdoo","year":"2012","unstructured":"McAdoo SP, Hall A, Levy J, et al. Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis. J Clin Rheumatol. 2012;18:336\u201340.","journal-title":"J Clin Rheumatol."},{"key":"240_CR26","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1681\/ASN.V10112446","volume":"10","author":"DC Kluth","year":"1999","unstructured":"Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc Nephrol. 1999;10:2446\u201353.","journal-title":"J Am Soc Nephrol"},{"key":"240_CR27","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1681\/ASN.2010090928","volume":"22","author":"SW Olson","year":"2011","unstructured":"Olson SW, Arbogast CB, Baker TP, et al. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol. 2011;22:1946\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"240_CR28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1160\/TH08-12-0825","volume":"102","author":"T Matsuyama","year":"2009","unstructured":"Matsuyama T, Kuwana M, Matsumoto M, et al. Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Thromb Haemost. 2009;102:371\u20138.","journal-title":"Thromb Haemost"},{"key":"240_CR29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2215\/CJN.07910814","volume":"10","author":"SF Chen","year":"2015","unstructured":"Chen SF, Wang H, Huang YM, et al. Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Clin J Am Soc Nephrol. 2015;10:750\u20138.","journal-title":"Clin J Am Soc Nephrol."},{"key":"240_CR30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s10157-010-0312-1","volume":"14","author":"H Watanabe","year":"2010","unstructured":"Watanabe H, Kitagawa W, Suzuki K. Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Clin Exp Nephrol. 2010;14:598\u2013601.","journal-title":"Clin Exp Nephrol."}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-016-0240-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-016-0240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-016-0240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T16:40:53Z","timestamp":1657557653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-016-0240-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["240"],"URL":"https:\/\/doi.org\/10.1007\/s13730-016-0240-3","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]}}}